1. Home
  2. TSBX vs CELZ Comparison

TSBX vs CELZ Comparison

Compare TSBX & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSBX
  • CELZ
  • Stock Information
  • Founded
  • TSBX 2015
  • CELZ 1998
  • Country
  • TSBX United States
  • CELZ United States
  • Employees
  • TSBX N/A
  • CELZ N/A
  • Industry
  • TSBX
  • CELZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • TSBX
  • CELZ Health Care
  • Exchange
  • TSBX Nasdaq
  • CELZ Nasdaq
  • Market Cap
  • TSBX 7.7M
  • CELZ 7.4M
  • IPO Year
  • TSBX 2023
  • CELZ N/A
  • Fundamental
  • Price
  • TSBX $0.36
  • CELZ $2.75
  • Analyst Decision
  • TSBX Buy
  • CELZ
  • Analyst Count
  • TSBX 3
  • CELZ 0
  • Target Price
  • TSBX $4.75
  • CELZ N/A
  • AVG Volume (30 Days)
  • TSBX 471.7K
  • CELZ 233.9K
  • Earning Date
  • TSBX 08-13-2025
  • CELZ 08-08-2025
  • Dividend Yield
  • TSBX N/A
  • CELZ N/A
  • EPS Growth
  • TSBX N/A
  • CELZ N/A
  • EPS
  • TSBX N/A
  • CELZ N/A
  • Revenue
  • TSBX N/A
  • CELZ $14,000.00
  • Revenue This Year
  • TSBX N/A
  • CELZ N/A
  • Revenue Next Year
  • TSBX N/A
  • CELZ N/A
  • P/E Ratio
  • TSBX N/A
  • CELZ N/A
  • Revenue Growth
  • TSBX N/A
  • CELZ 55.56
  • 52 Week Low
  • TSBX $0.29
  • CELZ $1.69
  • 52 Week High
  • TSBX $2.65
  • CELZ $6.90
  • Technical
  • Relative Strength Index (RSI)
  • TSBX 53.01
  • CELZ 50.66
  • Support Level
  • TSBX $0.33
  • CELZ $2.34
  • Resistance Level
  • TSBX $0.37
  • CELZ $2.74
  • Average True Range (ATR)
  • TSBX 0.01
  • CELZ 0.27
  • MACD
  • TSBX -0.00
  • CELZ -0.05
  • Stochastic Oscillator
  • TSBX 74.50
  • CELZ 15.08

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

About CELZ Creative Medical Technology Holdings Inc.

Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.

Share on Social Networks: